Douglas Gladstone named chief of hematologic malignancies at Northwell Health

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.

October 25, 2024

Vol.50 No.40

In Brief

Kevin Holcomb joins Northwell as chair of obstetrics and gynecology

Kevin Holcomb will join Northwell Health as chair of the Department of Obstetrics and Gynecology at North Shore University Hospital in Manhasset, Long Island Jewish Medical Center in New Hyde Park, and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale.

October 04, 2024

Vol.50 No.37

In Brief

Abhisek Swaika named medical director of Northwell at Rego Park, chief of hem/onc at Jewish Forest Hills Hospital

Abhisek Swaika was named medical director of the Northwell Health Cancer Institute at Rego Park and chief of hematology/oncology at Long Island Jewish Forest Hills Hospital.

September 06, 2024

Vol.50 No.33

In Brief

Steven Mitchell Cohen named director of robotic pancreas surgery at Northwell

Steven Mitchell Cohen was named director of robotic pancreas surgery at the Northwell Health Cancer Institute.

August 09, 2024

Vol.50 No.32

In Brief

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Michael Seidman has joined Fox Chase Cancer Center as a professor in the Department of Hematology/Oncology.

August 09, 2024

Vol.50 No.32

Conversation with The Cancer Letter

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

July 12, 2024

Vol.50 No.28

By Matthew Bin Han Ong

Douglas Gladstone named chief of hematologic malignancies at Northwell Health

YOU MAY BE INTERESTED IN

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Kevin Holcomb joins Northwell as chair of obstetrics and gynecology

Abhisek Swaika named medical director of Northwell at Rego Park, chief of hem/onc at Jewish Forest Hills Hospital

Steven Mitchell Cohen named director of robotic pancreas surgery at Northwell

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

Renew today!

Subscriber content

Login

Douglas Gladstone named chief of hematologic malignancies at Northwell Health

YOU MAY BE INTERESTED IN

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Kevin Holcomb joins Northwell as chair of obstetrics and gynecology

Abhisek Swaika named medical director of Northwell at Rego Park, chief of hem/onc at Jewish Forest Hills Hospital

Steven Mitchell Cohen named director of robotic pancreas surgery at Northwell

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Infections are a major cause of death in patients treated with CAR T-cell therapyMeta-analysis focused on causes of death, excluding relapse, recurrence

Login

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence